Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder: Results From the AtWoRC
Pratap Chokka1, Anders Holmegaard Tvistholm, Joanna Bougie
1Grey Nuns Community Hospital, Edmonton, Alberta, Canada (Dr Chokka); H. Lundbeck A/S, Valby, Denmark (Mr Tvistholm, Dr Ettrup); and Lundbeck Canada Inc., Montreal, Quebec, Canada (Dr Bougie, Dr Clerzius).
Objective:
To assess changes in workplace productivity and functioning in an open-label study in working patients receiving vortioxetine (10 to 20 mg/d) for major depressive disorder (MDD).
Methods:
Associations between items in the Work Limitations Questionnaire (WLQ), the Sheehan Disability Scale (SDS), and the Work Productivity and Activity Impairment (WPAI) questionnaire were assessed at 12 and 52 weeks by Pearson correlation coefficients.
Results:
Significant improvements were observed across all domains of workplace productivity and functioning after 12 and 52 weeks' vortioxetine treatment. Strong correlations were seen between improvements in WLQ mental domains and WPAI presenteeism and SDS work/school items. Presenteeism showed stronger correlations with other workplace productivity measures than absenteeism.
Conclusions:
Presenteeism and absenteeism impact productivity in working patients with MDD. Vortioxetine confers long-term benefits across all workplace functioning domains.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Depression: Overview
The Placebo Effect

